News

Published on 6 Apr 2022 on Benzinga

51 Biggest Movers From Yesterday

Article preview image

Don’t forget to check out our premarket coverage here .

Read the rest of the article
NASDAQ.ENSC price evolution
NASDAQ.LHDX price evolution
NYSE.RCUS price evolution
NASDAQ.INZY price evolution
NASDAQ.PRPO price evolution
NASDAQ.ASUR price evolution
NASDAQ.CCCC price evolution
NASDAQ.SAVA price evolution
NASDAQ.DLPN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Cassava Sciences' Alzheimer's drug continues Phase 3 trials

Cassava Sciences' Alzheimer's drug continues Phase 3 trials

Investing.com 25 Mar 2024
Cassava Alzheimer's candidate simufilam clears phase 3 safety review

Cassava Sciences Alzheimers candidate simufilam receives recommendation to continue its phase 3...

Seeking Alpha 25 Mar 2024
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report - Cassava Sciences...

The credibility of the clinical trial results for an experimental Alzheimer’s drug has been calle...

Benzinga 12 Mar 2024
BA, ORCL, META, SAVA, TSLA: Why These 5 Stocks Are Trending Today - WisdomTree Industrial Metals...

On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to tu...

Benzinga 12 Mar 2024
Bullish Cassava Sciences Insiders Loaded Up On US$3.12m Of Stock

Quite a few insiders have dramatically grown their holdings in Cassava Sciences, Inc. (NASDAQ:SAV...

Simply Wall St. via Yahoo Finance 6 Mar 2024
Cassava Sciences reports solid financial stance

Cassava Sciences, Inc. (NASDAQ: SAVA ), a biotech firm targeting Alzheimer's disease, disclosed i...

Investing.com 28 Feb 2024
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam...

ADAS-Cog Scores Were Stable in a Group of Patients with Mild Alzheimer's Who Received Drug Candid...

Investing.com 7 Feb 2024
Simufilam shows stable scores in mild Alzheimer's study By Investing.com

Simufilam shows stable scores in mild Alzheimer's study

Investing.com 7 Feb 2024
Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending - Cassava Sciences (NASDAQ:SAVA)

Cassava Sciences, Inc. SAVA shares are trading higher Wednesday after the company reported top-li...

Benzinga 7 Feb 2024
Cassava Sciences, Inc. (NASDAQ:SAVA): Is Breakeven Near?

With the business potentially at an important milestone, we thought we'd take a closer look at Ca...

Simply Wall St. via Yahoo Finance 9 Nov 2023

Copyright Statfolio @ 2024

Social Accounts